Award for Donepezil Tablets with Lucid Pharma Effective 6/18/15-6/17/2016

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) VA797P-15-R-0057 for an unrestricted procurement for Donepezil HCL Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the lowest price, responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items, whose offer is considered technically acceptable, and whose prices are determined fair and reasonable. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA's and DOD's respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. This solicitation will be electronically issued in commercial item format in accordance with FAR Part 12 on or about March 3, 2015, with a tentative closing date of April 9, 2015. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Lani Nishimura. Questions can be e-mailed to: Lani.Nishimura@va.gov.



All unit-of-use packaging identified in the Schedule of Supplies, (i.e., 30s, 90s), must contain a child proof closure (safety cap) and a bottle with a minimum required size of 100cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75" circumference. The bottle must fit a label with a dimension of 5.25" x 2". The 0.5" additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Glass bottles are not acceptable. The solicitation will have further instructions on this requirement.



The estimated annual requirements are as follows:



DESCRIPTION



1. DONEPEZIL HCL 10MG TAB

PACKAGE SIZE (BOTTLES) 30

TOTAL ESTIMATED ANNUAL USAGE (BOTTLES) 94,421



2. DONEPEZIL HCL 10MG TAB

PACKAGE SIZE (BOTTLES) 90

TOTAL ESTIMATED ANNUAL USAGE (BOTTLES) 120,628



3. DONEPEZIL HCL 10MG TAB

PACKAGE SIZE (BOTTLES) 500

TOTAL ESTIMATED ANNUAL USAGE (BOTTLES) 14,208



OR



DONEPEZIL HCL 10MG TAB

PACKAGE SIZE (BOTTLES) 1,000

TOTAL ESTIMATED ANNUAL USAGE (BOTTLES) 7,104



4. DONEPEZIL HCL 5MG TAB

PACKAGE SIZE (BOTTLES) 30

TOTAL ESTIMATED ANNUAL USAGE (BOTTLES) 28,670



5. DONEPEZIL HCL 5MG TAB

PACKAGE SIZE (BOTTLES) 90

TOTAL ESTIMATED ANNUAL USAGE (BOTTLES) 28,911



6. DONEPEZIL HCL 5MG TAB

PACKAGE SIZE (BOTTLES) 500

TOTAL ESTIMATED ANNUAL USAGE (BOTTLES) 1,614



OR



DONEPEZIL HCL 5MG TAB

PACKAGE SIZE (BOTTLES) 1000

TOTAL ESTIMATED ANNUAL USAGE (BOTTLES) 807